China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE: 300294)
China
· Delayed Price · Currency is CNY
29.63
-0.04 (-0.13%)
Jan 3, 2025, 3:04 PM CST
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Revenue
China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of 349.37M CNY in the quarter ending September 30, 2024, a decrease of -46.21%. This brings the company's revenue in the last twelve months to 1.71B, down -40.46% year-over-year. In the year 2023, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had annual revenue of 2.65B, down -3.87%.
Revenue (ttm)
1.71B
Revenue Growth
-40.46%
P/S Ratio
8.76
Revenue / Employee
1.18M
Employees
1,444
Market Cap
14.94B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.65B | -106.72M | -3.87% |
Dec 31, 2022 | 2.76B | 108.17M | 4.08% |
Dec 31, 2021 | 2.65B | 137.49M | 5.47% |
Dec 31, 2020 | 2.51B | -395.73M | -13.60% |
Dec 31, 2019 | 2.91B | 521.25M | 21.83% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shenzhen Mindray Bio-Medical Electronics | 37.11B |
Jiangsu Hengrui Medicine | 26.00B |
WuXi AppTec | 38.50B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
Aier Eye Hospital Group | 20.62B |
Shanghai United Imaging Healthcare | 10.93B |
Yunnan Baiyao Group Co.,Ltd | 39.34B |
Beijing Wantai Biological Pharmacy Enterprise | 2.49B |